Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-30

Clinical Trial Update: Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating metronomic chemotherapy (vinorelbine, cyclophosphamide, and interferon alfa-2b) with pharmacodynamic assessments in adults with advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Interferon-alpha-2b (interferon alfa-2b)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Advanced Neoplasm | Phase 1 | Status: COMPLETED